0.97
+0.0821(+9.26%)
Currency In USD
Address
65 Yigal Alon Street
Tel Aviv, 6745442
Israel
Phone
972 3 717 7050
Website
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
2
First IPO Date
September 01, 2020
| Name | Title | Pay | Year Born |
| Dr. Ehud Geller Ph.D. | Interim Chief Executive Officer & Executive Chairman | 150,000 | N/A |
| Prof. Eli Hazum Ph.D. | Chief Technology Officer & Director | 144,000 | N/A |
| Mr. Eyal Broder | Interim Chief Financial Officer | 235,000 | 1971 |
| Ms. Rita Keynan | Vice President of Pharmaceutical Operations | 287,000 | 1969 |
| Dr. Sigal Aviel eMBA, Ph.D. | Chief Operating Officer | 330,000 | 1964 |
| Dr. Stephen A. Cooper D.M.D Ph.D. | Executive Vice President of Development | 0 | N/A |
PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. It engages in developing PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. The company is currently conducting two Phase 3 clinical trials of PRF-110 for the treatment of patients undergoing bunionectomy surgery and hernia repair. PainReform Ltd. was incorporated in 2007 and is based in Tel Aviv, Israel.